Investment

Manufacturing Job Creation Public Investment Government Funding Research and Development Dublin Development Clinical Trials International Business Private Equity

6 ARTICLES

last mo.

Roche Announces $50 Billion U.S. Investment in Response to Tariff Concerns

The pharmaceutical giant's five-year plan includes new R&D hubs, expanded manufacturing, and over 12,000 jobs as the industry braces for potential White House tariffs.

4 ARTICLES

last mo.

AstraZeneca Cancels £450m UK Vaccine Plant Investment

Investment

Roche Announces $50 Billion U.S. Investment in Response to Tariff Concerns

Roche Announces $50 Billion U.S. Investment to Expand R&D and Manufacturing

Novartis Confirms $23 Billion U.S. Investment with Major Expansion Plans

Novartis Announces $23 Billion U.S. Expansion with New Plants and R&D Hub

AstraZeneca Announces $2.5 Billion Beijing R&D Hub to Bolster China Presence

AstraZeneca Cancels £450m UK Vaccine Plant Expansion Over Funding Dispute

AstraZeneca Cancels £450m UK Vaccine Plant Investment